• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

Thursday, 12 March 2020 / Published in Medical Device, News

China’s Coronavirus Emergency Response for Urgently Needed Medical Devices

Since the Coronavirus outbreak, the prevention and control work were deployed as the top priority of the China government at all levels. Due to the urgent demand of overseas medical products, the registration process was expedited to follow the Emergency Examine and Approval Procedure for Medical Device (No.565-2009) that was officially released in August 2009 by the State Food and Drug Administration (former NMPA).

According to the Procedure, the registration approval can be received as soon as five days and the registration tests will be carried out within 24 hours after receiving the samples. Once the registration application is accepted, the technical review and the administrative approval will be completed by the food and drug administrative departments within a time period subjected to the classification of the medical devices as listed in the table below:

The number of institutions are listed with the respective testing capability in the table below:

Medical Device

Technical ReviewAdministrative Approval

Class I

5 Days

Class II

5 Days3 Days

Class III

10 Days3 Days

During the past two months, medical products were urgently approved through the expedited process to help control the epidemic situation.

26.01.2020 – 4 Novel Coronavirus Detection products were urgently approved

28.01.2020 – 2 Nucleic Acid Detection Reagents were urgently approved

31.01.2020 – 1 Nucleic Acid Detection Reagents were urgently approved

05.02.2020 – An accumulated total of 72 medical products were urgently approved.

07.02.2020 – The urgent approval of medical protective clothing was announced

12.02.2020 – Important notes for the technical approval of Nucleic Acid Detection were announced

24.02.2020 – An accumulated total of 339 medical products and 7 Nucleic Acid Detection Reagents were urgently approved

11.03.2020 – An accumulated total of 10 Nucleic Acid Detection Reagents and 6 Antibody Detection Reagents were urgently approved

As of 05.03.2020, the CAME (China Association of Medical Equipment), a business unit under the China’s Ministry of Health, released 4 batches of urgently needed medical devices and IVDs for Coronavirus prevention and treatment, and approximately 25% of the products were produced by foreign manufacturers.

During this critical period, overseas medical products are considered to bring higher standards and innovative technologies for epidemic prevention in China. Due to this great demand, foreign manufacturers are encouraged by the Chinese government to enter the market.

Tagged under: Emergency Examine and Approval Procedure for Medical Device, medical device

What you can read next

Fast-Track Approval Updates in October & November 2020
Successful Project Launch of Chery Jaguar Land Rover (CJLR)
AI Regulatory Developments and Planning Issued by China Regulator

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP